Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling

BACKGROUND: Anti TNF drugs have been widely used in rheumatoid arthritis (RA) but only 70 to 80 % of patients respond to this therapy. Exploring the mode of action of anti-TNF drugs remains important in order to improve the efficiency of the treatment and enhance our knowledge of inflammation. TNF-α...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyer, Jean Frédéric, Baron, Michel, Constantin, Arnaud, Degboé, Yannick, Cantagrel, Alain, Davignon, Jean-Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774095/
https://www.ncbi.nlm.nih.gov/pubmed/26932562
http://dx.doi.org/10.1186/s13075-016-0955-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774095/
https://www.ncbi.nlm.nih.gov/pubmed/26932562
http://dx.doi.org/10.1186/s13075-016-0955-8

Ejemplares similares